Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2002

View Archived Issues

Robust thermogenic responses elicited by new beta3-adrenoceptor agonists identified at GSK

Imunovir distribution agreement for North America extended

Curis reports evidence for a unique mechanism for the renal effects of BMP-7

Potent hypoglycemic and hypolipidemic agent interacting with PPARgamma identified at Takeda

Company Profile: Basilea Pharmaceutica

Bio-Technology General initiates phase I study of Puricase in gout

Pharmacia licenses Nastech's nasally administered apomorphine for ED & FSD

Prana awarded grant for research into age-related diseases

Once-daily one-tablet formulation of Sustiva approved

Fast track designation for Oncophage in metastatic melanoma

Transglutaminase inhibitor improves survival and symptoms in transgenic Huntington's disease mice

EMEA accepts vardenafil submission for treatment of ED

Initiation of phase I clinical trial of XR-11576 in treatment of solid tumors

Medtronic's Activa Parkinson's Control Therapy receives FDA approval

Efalizumab to be evaluated in rheumatoid arthritis

New Janssen compounds with fundic relaxant activity

Polymer-based analgesic successfully completes first clinical trial at A.P. Pharma

AstraZeneca claims compounds which modulate chemokine receptors

AtheroGenics identifies inhibitors of VCAM-1 expression

Servier scientists prepare novel podophyllotoxin derivatives for cancer Rx

Potent and selective PDE7 inhibitors discovered at Celltech

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...